E
Eduard Maron
Researcher at Imperial College London
Publications - 83
Citations - 2729
Eduard Maron is an academic researcher from Imperial College London. The author has contributed to research in topics: Anxiety & Panic disorder. The author has an hindex of 29, co-authored 80 publications receiving 2364 citations. Previous affiliations of Eduard Maron include Tartu University Hospital & Centre for Mental Health.
Papers
More filters
Journal ArticleDOI
Variation in tryptophan hydroxylase-2 gene is not associated to male completed suicide in Estonian population.
TL;DR: The finding does not support the hypothesis of TPH2 being a susceptibility factor for completed suicide in males of Estonian origin and any associations between 14 single nucleotide polymorphisms and completed suicide were revealed.
Journal ArticleDOI
Whole-genome expression analysis reveals genes associated with treatment response to escitalopram in major depression
Kristi Pettai,Lili Milani,Anu Tammiste,Urmo Võsa,Raivo Kolde,Triin Eller,David J. Nutt,Andres Metspalu,Eduard Maron,Eduard Maron +9 more
TL;DR: The results of this study support that exploration of peripheral gene expression is a useful tool in the further identification of novel genetic biomarkers for antidepressant treatment response.
Journal ArticleDOI
Precision psychiatry in clinical practice.
Raffaella Zanardi,Dario Prestifilippo,Chiara Fabbri,Chiara Fabbri,Cristina Colombo,Eduard Maron,Eduard Maron,Alessandro Serretti +7 more
TL;DR: Only genetic variants in cytochrome enzymes are endorsed by prescribing guidelines, but in the future polygenic predictors of treatment outcomes may be translated into the clinic and represented an important step towards precision psychiatry.
Journal Article
The role of IL-2 and soluble IL-2R in depression and antidepressant response.
TL;DR: There has been no consistent pattern in the associations observed between cytokine concentration, or changes thereof, and clinical indices of major depression and one intriguing question is whether pretreatment levels of immune system markers, such as IL-2R alpha, can be used to predict responses to antidepressant treatment.
Journal ArticleDOI
Thyroid autoimmunity and treatment response to escitalopram in major depression.
TL;DR: Thyroid autoimmunity might be a factor predicting treatment response to antidepressants in depressive patients, and the last group showed a trend for a higher prevalence of anti-TPO compared with responders.